Medpace Investor Relations Material
Latest events
Q1 2025
Medpace
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medpace Holdings Inc
Access all reports
Medpace Holdings Inc., a full-service clinical research organization, provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers therapeutic expertise in the areas of endocrinology, gastroenterology, general medicine, hematology/oncology, infectious diseases/vaccines, and neuroscience.
Key slides for Medpace Holdings Inc
Q1 2025
Medpace Holdings Inc
Q1 2025
Medpace Holdings Inc
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
MEDP
Country
🇺🇸 United States